Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...

India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on ...

Wholesale prices are in the gutter across much of Europe, forcing drug smugglers to try and manipulate the market. OCCRP ...

More than two weeks after President Donald Trump said he would halt “all payments” to Colombia, there has not been any ...

New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot ...

Sarepta nevertheless plans to push for full FDA approval of Vyondys 53 and Amondys 45 based on what it said are “encouraging ...

Indigenous communities on the remote border between Peru and Brazil are alarmed over the growing presence of Brazil's Comando ...

Comprehensive meeting with FDA conducted in Q3 in conjunction with Breakthrough Therapy Designation Key aspects of a ...